Skip to main content
SpringerLink
Log in

Subclinical thyroid disorders: The menace of the Trojan horse

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

This review aims at summarizing some new data regarding the so-called subclinical thyroid disease and incorporate the knowledge in order to provide a basis for a more careful approach to these morbidities. SHyper represents a considerable risk factor for atrial fibrillation in the elderly and also for osteoporosis, which is a major cause of morbidity in postmenopausal women. SHypo is not an innocuous condition. It progresses to thyroid failure in patients with positive thyroid antibodies, it affects neurobehavior, it may influence cardiac contractility at exercise and it is associated with an impaired lipid profile that may provoke atherosclerosis. Therefore, both conditions should be screened more carefully in the community and treatment should be more often considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Evered D., Hall R. Hypothyroidism. B.M.J. 1972, 1: 290–293.

    Article  CAS  Google Scholar 

  2. Gemsenjäger E., Staub J.J., Girard J., Heitz P.H. Preclinical hyperthyroidism in multinodular goiter. J. Clin. Endocrinol. Metab. 1976, 43: 810–816.

    Article  PubMed  Google Scholar 

  3. Evered D.C., Ormston B.J., Smith P.A., Hall R., Bird T. Grades of hypothyroidism. B.M.J. 1973, 1: 657–662.

    Article  CAS  Google Scholar 

  4. Ayala A.R., Wartofsky L. The case for more aggressive screening and treatment of mild thyroid failure. Cleve. Clin. J. Med. 2002, 4: 313–320.

    Article  Google Scholar 

  5. Wilansky D.L., Greisman B. Early hypothyroidism in patients with menorrhagia. Am. J. Obstet. Gynecol. 1989, 160: 673–677.

    Article  PubMed  CAS  Google Scholar 

  6. Duntas L.H. Subclinical hypothyroidism: A misnomer in search of a new name. Thyroid 2001, 11: 361–362.

    Article  PubMed  CAS  Google Scholar 

  7. Laurberg P., Bulow-Pedersen I., Knudsen N., Oversen L., Andersen S. Environmental iodine intake affects the type of non-malignant thyroid disease. Thyroid 2001, 11: 457–469.

    Article  PubMed  CAS  Google Scholar 

  8. Vanderpump M.P.J, Tunbridge W.M.G., French J.M., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf.) 1995, 43: 55–68

    Article  CAS  Google Scholar 

  9. Sawin C.T., Geller A., Kaplan M.M., Bacharach P., Wilson P.W.F., Hershman J.M. Low serum thyrotropin (Thyroid- Stimulating-Hormone) in older persons without hyperthyroidism. Arch. Intern. Med. 1991, 151: 165–168.

    Article  PubMed  CAS  Google Scholar 

  10. Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000, 160: 526–534.

    Article  PubMed  CAS  Google Scholar 

  11. Hollowell J.C., Staehling N.W., Hannon W.H., et al. Serum thyrotropin, thyroxine, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Exmination Survey (NHANES III). J. Clin. Endocrinol. Metab. 2002, 87: 489–499.

    Article  PubMed  CAS  Google Scholar 

  12. Bartalena L., Martino F., Velluzzi M., et al. The lack of nocturnal serum thyrotropin surge in patients with nontoxic nodular goiter may predict the subsequent occurrence of hyperthyroidism. J. Clin. Endocrinol. Metab. 1991, 73: 604–608.

    Article  PubMed  CAS  Google Scholar 

  13. Spencer C.A., Schwarzbein D., Guttler R.B., LoPresti J.S., Nicoloff J.T. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and forth generation TSH assays. J. Clin. Endocrinol. Metab. 1993, 76: 494–498.

    PubMed  CAS  Google Scholar 

  14. Fatourechi V. Adverse effects of subclinical hyperthyroidism. Lancet 2001, 358: 856–857.

    Article  PubMed  CAS  Google Scholar 

  15. Subclinical hyperthyroidism: position statement from the American Association of Clinical Endocrinologists. Endocrine Practice 1999, 5: 220–221.

    Google Scholar 

  16. Braverman L.E., Pearce E.N. Subclinical hyperthyroidism Thyroid International 2001, 5: 3–11.

    Google Scholar 

  17. Parle J.V., Franklyn J.A., Cross K.W., Jones S.C., Sheppard M.C. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin. Endocrinol. (Oxf.) 1991, 34: 77–83.

    Article  CAS  Google Scholar 

  18. Schlote-Sautter B., Schmidt R., Kaumeier S., Teuber J., Vardarli I., Usaldel K.H. Subclinical hyperthyroidism: do physical and mental symptoms exist that justify treatment? In: Reinwein D. and Scriba P.C. (Eds.), The various types of hyperthyroidism. Urban & Schwartzenberg, Munich, 1990, p. 319.

    Google Scholar 

  19. Muente T.F., Radamm C, Soenke J., Brabant G. Alererations of cognitive functions induced by exogenous application of thyroid hormones in healthy men: a doubleblind cross-over study using event-related brain potentials. Thyroid 2001, 11: 385–391.

    Article  Google Scholar 

  20. Eriksen E.F. Normal and pathological remodelling of human trabecular bone: three dimensional reconstruction of the remodelling sequence in normals and in metabolic bone disease. Endocr. Rev. 1986, 7: 379–408.

    Article  PubMed  CAS  Google Scholar 

  21. Ross D.S. Subclinical hyperthyroidism. In: Braverman L.E., Utiger R.D. (Eds.), Werner and Ingbar’s The Thyroid, ed. 6. J.B. Lippincott Company, Philadelphia, 1991, p. 1249.

    Google Scholar 

  22. Ross D.S., Neer R.M., Ridgway R.C., Daniels G.H. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with l-thyroxine. Am. J. Med. 1987, 82: 1167–1170.

    Article  PubMed  CAS  Google Scholar 

  23. Grant D.J., McMurdo M.E.T., Mole P.A., Paterson C.R., Davies R.R. Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis. Clin. Endocrinol. (Oxf.) 1993, 39: 529–533.

    Article  CAS  Google Scholar 

  24. Faber, J., Galloe A.M. Changes in bone mass during prolonged subclinical hyperthyroidism due to l-thyroxine treatment: a meta-analysis. Eur. J. Endocrinol. 1994, 130: 350–356.

    Article  PubMed  CAS  Google Scholar 

  25. Marcocci C., Golia F., Vignali E., Pinchera A. Skeletal integrity in men chronically treated with suppressive doses of l-thyroxine. J. Bone Min. Res. 1997, 12: 72–77.

    Article  CAS  Google Scholar 

  26. Gurlek K.A., Cedik O. Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Thyroid 1999, 9: 539–543.

    Article  PubMed  CAS  Google Scholar 

  27. Faber J., Jensen I.W., Petersen L., Nygaard B., Hegedus L., Siersbaek N.K. Normalization of serum thyrotropin by means of radiodine treatment in subclinical hyperthyroidism: Effect on bone loss in postmenopausal women. Clin. Endocrinol. (Oxf.) 1998, 48: 285–290.

    Article  CAS  Google Scholar 

  28. Guo C.Y., Weetman A.P., Eastell R. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin. Endocrinol. (Oxf.) 1997, 46: 301–307.

    Article  CAS  Google Scholar 

  29. Uzzan B., Campos J., Cucherat M., Nony P., Boissel J.P., Perret G.Y. Effects on bone mass of long term treatment with thyroid hormones: A meta-analysis. J. Clin. Endocrinol. Metab. 1996, 81: 4278–4289.

    PubMed  CAS  Google Scholar 

  30. Bauer D.C, Ettinger B, Nevitt M.C., Stone K.L. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann. Intern. Med. 2001, 134: 561–568.

    Article  PubMed  CAS  Google Scholar 

  31. Klein I. Thyroid hormone and the cardiovascular system. Am. J. Med. 1990, 88: 631–637.

    Article  PubMed  CAS  Google Scholar 

  32. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 2001, 7: 501–509

    Google Scholar 

  33. Mercuro G., Panzuto M..G., Bina A., et al. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J. Clin. Endocrinol. Metab. 2000, 85: 159–164.

    Article  PubMed  CAS  Google Scholar 

  34. Biondi B., Palmieri E.A., Fazio S., et al. Endogenous subclinical hyperthyroidism affects quality of life, cardiac morphology and function in young and middle-aged patients. J. Clin. Endocrinol. Metab. 2000, 12: 4701–4705.

    Google Scholar 

  35. Sawin C.T., Geller A., Wolf P.A., et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N. Engl. J. Med. 1994, 331: 1249–1252.

    Article  PubMed  CAS  Google Scholar 

  36. Auer J., Scheibner P., Mische T., Langsteger W., Eber O., Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am. Heart J. 2001, 142: 838–842.

    Article  PubMed  CAS  Google Scholar 

  37. Ladenson P.W. Thyrotoxicosis and the heart: old and something new. J. Clin. Endocrinol. Metab. 1993, 77: 332–333.

    PubMed  CAS  Google Scholar 

  38. Kalmijn S., Mehta K.M., Pols H.A.P., Hofman A., Drexhage H.A., Breteler M.M.B. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin. Endocrinol. (Oxf.) 2000, 53: 733–737.

    Article  CAS  Google Scholar 

  39. Parle J.V., Maisonneuve P., Sheppard M.C., Boyle P., Franklyn J.A. Prediction of all cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10 year cohort study. Lancet 2001, 385: 861–865.

    Article  Google Scholar 

  40. Shrier D.K., Burman K.D. Subclinical hyperthyroidism: controversies in management. Am. Fam. Physician 2002, 3: 431–438.

    Google Scholar 

  41. Levy E.G. (section editor). Subclinical hyperthyroidism. Thyroid 2000, 10: 721–723.

  42. Sawin C.T. Subclinical hyperthyroidism and atrial fibrillation. Thyroid 2002, 6: 501–503.

    Article  Google Scholar 

  43. Tunbridge W.M., Evered D.C., Hall R., et al. Lipid profiles and cardiovascular disease in the Wickham area with particular reference to thyroid failure. Clin. Endocrinol. (Oxf.) 1977, 7: 495–508.

    Article  CAS  Google Scholar 

  44. Sawin C.T., Castelli W.P., Hershman J.M., Mc Namara P., Bacharach P. The aging thyroid: Thyroid deficiency in the Framingham Study. Arch. Intern. Med. 1985, 145: 1386–1388.

    Article  PubMed  CAS  Google Scholar 

  45. Duntas L.H. Recap of the clinical use of thyrotropin-releasing hormone. In: Duntas L.H. and Guillemin R. (Eds.), Hypothalamic Releasing Hormones. Challenges and perspectives at the 2000 year mark. Beta Medical Arts, Athens, 2000, p.31.

    Google Scholar 

  46. Faglia G. The clinical impact of thyrotropin-releasing hormone test. Thyroid 1998, 10: 903–908.

    Article  Google Scholar 

  47. Michalakopoulou G., Alevizaki M., Piperingos G., et al. High serum cholesterol levels in persons with “high-normal” TSH levels: should one extend the definition of subclinical hypothyroidism? Eur. J. Endocrinol. 1998, 138: 141–145.

    Article  Google Scholar 

  48. Lekakis J., Papamichael C., Alevizaki M., et al. Flow-mediated endothelium dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism and high-normal serum thyrotropin (TSH) values. Thyroid 1997, 7: 411–414.

    Article  PubMed  CAS  Google Scholar 

  49. Cooper D.S. Subclinical hypothyroism. N. Engl. J. Med. 2001, 345: 260–265.

    Article  PubMed  CAS  Google Scholar 

  50. Ladenson P.W., Singer P.A., Ain K.B., et al. American Thyroid Association guidelinesfor detection of thyroid dysfunction. Arch. Intern. Med. 2000, 160: 1573–1575.

    Article  PubMed  CAS  Google Scholar 

  51. Danese M.D., Powe N.R., Sawin C.T., Ladenson P.W. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. J.A.M.A. 1996, 276: 285–292.

    Article  PubMed  CAS  Google Scholar 

  52. Haddow J.E., Palomaki G.E., Allan W.C., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsycho- logical development of the child. N. Engl. J. Med. 1999, 341: 549–555.

    Article  PubMed  CAS  Google Scholar 

  53. Klein R.Z., Sargent J.D., Larsen P.R., Waisbren S.E., Haddow J.E., Mitchell M.L. Relation of severity of maternal hypothyroidism to cognitive development of offspring. J. Med. Screen. 2001, 1: 18–20.

    Article  Google Scholar 

  54. Davies P.H., Franklyn J.A. The effect of drugs on tests of thyroid function. Eur. J. Clin. Pharmacol. 1991, 40: 439–451.

    Article  PubMed  CAS  Google Scholar 

  55. Asher R. Myxedematous madness. B.M.J. 1949, 22: 555–562.

    Article  Google Scholar 

  56. Nemeroff C.B. Subclinical hypothyroidism: a review of neuropsychiatric aspects. Int. J. Psychiatry Med. 1990, 20: 193–208.

    Article  PubMed  Google Scholar 

  57. Haggerty J.J., Stern R.A., Mason G.A., Beckwith J., Morey C.E., Prange A.J. Jr. Prevalence of antithyroid antibodies in mood disorders. Am. J. Psychiatry 1993, 3: 508–510.

    Google Scholar 

  58. Berlin I., Payan C., Corruble E., Puech A.J. Serum thyroidstimulating- hormone concentration as an index of severity of major depression. Int. J. Neuropsychopharmacol. 1999, 2: 105–110.

    Article  PubMed  CAS  Google Scholar 

  59. Nystroem E., Caidahl K., Fager G., Wikkelso C., Lundberg P.A., Lindstedt G. A double-blind cross-over 12-month study of l-thyroxine treatment of women with ‘subclinical hypothyroidism’. Clin. Endocrinol. (Oxf.) 1988, 1: 63–75.

    Article  Google Scholar 

  60. Monzani F., Caraccio N., Siciliano G., Manca L., Murri L., Ferannini E. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 1997, 82: 3315–3318.

    Article  PubMed  CAS  Google Scholar 

  61. Goulis D.G., Tsimpiris N., Delaroudis S., et al. Stapedial reflex: a biologic index found to be abnormal in clinical and subclinical hypothyroidism. Thyroid 1998, 8: 583–587

    Article  PubMed  CAS  Google Scholar 

  62. Duntas L.H., Papanastasiou L., Mantzou E., Koutras D.A. Incidence of sideropenia and effects of iron repletion treatment in women with subclinical hypothyroidism. Exp. Clin. Endocrinol. Diabetes 1999, 107: 356–360.

    Article  PubMed  CAS  Google Scholar 

  63. Tagliaferri M., Berselli M.E., Calo G., et al. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition and lipid profile. Obes. Res. 2001, 9: 196–201.

    Article  PubMed  CAS  Google Scholar 

  64. Benvenga S., Robbins S. Lipoprotein-thyroid hormone interactions. Trends Endocrinol. Metab. 1996, 4: 194–198.

    Article  Google Scholar 

  65. Duntas L. Thyroid disease and lipids. Thyroid 2002, 12: 287–293.

    Article  PubMed  CAS  Google Scholar 

  66. Tan K.C.B., Shiu S.W.M., Kung A.W.C. Plasma cholesteryl ester transfer protein activity in hyper-and hypothyroidism. J. Clin. Endocrinol. Metab. 1998, 83: 149–153.

    Google Scholar 

  67. Althaus B.U., Staub J.J., Ryff-de Leche A., Oberhaenslie A., Staehelin H.B. LDL/HDL changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin. Endocrinol. (Oxf.) 1988, 28: 157–163.

    Article  CAS  Google Scholar 

  68. Bindels A.J.G.H., Westerndorp R.G.J., Froehlich M., Seidell J.C., Blokstra A., Smelt A.H.M. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for casefinding. Clin. Endocrinol. (Oxf.) 1999, 50: 217–220.

    Article  CAS  Google Scholar 

  69. Bakker S.J.L., Ter Maaten J.C., Popp-Snijders C., Slaets J.P.J., Heine R.J., Gans R.O.B. The relationship between thyrotropin and low-density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J. Clin. Endocrinol. Metab. 2001, 86: 1206–1211.

    PubMed  CAS  Google Scholar 

  70. Vanderpump M.P., Tunbridge W.M., French J.M., et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of English community. Thyroid 1996, 6:155–160.

    PubMed  CAS  Google Scholar 

  71. Hak E.A., Huibert A.P., Visser T.J., Drexhage H.A., Hofman A. Witterman J.C.M. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study. Ann. Intern. Med. 2000, 132: 270–278.

    Article  PubMed  CAS  Google Scholar 

  72. Huber G. Staub J.J., Meier C. et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J. Cli. Endocrinol. Metab. 2002, 87: 3221–3226.

    Article  CAS  Google Scholar 

  73. Meier C., Staub J.J., Roth C.B., et al. TSH-controlled l-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo- contolled trial (Basel Thyroid Study). J. Clin. Endocrinol. Metab. 2001, 86: 4860–4866.

    Article  PubMed  CAS  Google Scholar 

  74. Danese M.D., Ladenson P.W., Meinert C.L., Powe N.R. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J. Clin. Endocrinol. Metab. 2000, 85: 2993–3001.

    PubMed  CAS  Google Scholar 

  75. Tanis B.C., Westerdorp G.J., Smelt H.M. Effect of thyroid substitution on hypercholesterolemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin. Endocrinol. (Oxf.) 1996, 44: 643–649.

    Article  CAS  Google Scholar 

  76. Alvarez J.J, Lasuncion M.A, Olmos J.M, Herrera E. Interindividual variation in the partition of lipoprotein (a) into lipoprotein subfractions. Clin. Biochem. 1993, 26: 399–408.

    Article  PubMed  CAS  Google Scholar 

  77. Pazos F., Alvarez J.J., Rubies-Prat J., Varela C., Lasuncion M.A. Long term thyroid hormone replacement therapy and levels of lipoprotein and other lipoproteins. J. Clin. Endocrinol. Metab. 80: 562–566.

  78. Danzi S., Klein I. Thyroid hormone-regulated cardia gene expression and cardiovascular disease. Thyroid 2002, 12: 467–472.

    Article  PubMed  CAS  Google Scholar 

  79. Kahaly G.J. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 2000, 10: 665–679

    Article  PubMed  CAS  Google Scholar 

  80. Arem R., Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arch. Intern. Med. 1990, 150: 2097–2100.

    CAS  Google Scholar 

  81. Biondi B., Fazio S., Palmieri E.A., et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 1999, 84: 2064–2067.

    Article  PubMed  CAS  Google Scholar 

  82. Foeldes J., Istvanfy M., Halmagyi M., Varadi A., Gara A, Partos O. Hypothyroidism and the heart examination of left ventricular function in subclinical hypothyroidism. Acta. Med. Hung. 1987, 44: 337–347.

    Google Scholar 

  83. Biondi B., Palmeri E.A., Lombardi G., Fazio S. Subclinical hypothyroidism and cardiac function. Thyroid 2002, 12: 505–510.

    Article  PubMed  Google Scholar 

  84. Cooper D.S., Halpern R., Wood L.C., Levin A.A., Ridgway E.C. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann. Intern. Med. 1984, 101: 18–24.

    CAS  Google Scholar 

  85. Faber J., Petersen L., Winberg N., Shifter S., Mehlsen J. Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid 2002, 10: 319–324.

    Article  Google Scholar 

  86. Chu J.W., Crapo L.M. The treatment of subclinical hypothyroidism is seldom necessary. J. Clin. Endocrinol. Metab. 2001, 86: 4591–4599.

    Article  PubMed  CAS  Google Scholar 

  87. Zulewski H., Mueller B., Exer P., Miserez A., Staub J.J. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J. Clin. Endocrinol. Metab. 1997, 82: 771–776.

    PubMed  CAS  Google Scholar 

  88. Andersen S., Pedersen K.M., Brunn N.H., Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 2002, 87: 1068–1072.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Unit, Evgenidion Hospital, University of Athens Medical School, 20 Papadiamantopoulou Str, 11528, Athens, Greece

    Leonidas H. Duntas

Authors
  1. Leonidas H. Duntas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leonidas H. Duntas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duntas, L.H. Subclinical thyroid disorders: The menace of the Trojan horse. J Endocrinol Invest 26, 472–480 (2003). https://doi.org/10.1007/BF03345205

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345205

Key-words

Search

Navigation